DIAGNOSTICS

n True False 3. To demonstrate clinical usefulness, a biomarker needs to show all of the following EXCEPT... a. Net reclassification improvement b. Adherence to ACC/AHA guidelines c. Discrimination capability d. Calibration to what is measured 4. Which of the following statements is TRUE about normal values for biomarkers? a. A health questionnaire is preferred over surrogate biomarkers for determining normal values in a population b. A standardized, normal range must be established for every biomarker marketed in the US and Europe, and this standard must be adhered to by all manufacturers c. T here is no standard for defining a normal population in studies of biomarkers or how that normal population is selected d. All of the above statements are true LEARNING GUIDE: CARDIAC 63 APPENDIX APPENDIX A: GLOSSARY OF TERMS APPENDIX B: CORRECT RESPONSES APPENDIX C: REFERENCES LEARNING GUIDE: CARDIAC 64 APPENDIX A: GLOSSARY OF TERMS A ACE inhibitors: A class of medication used to treat heart failure and high blood pressure; in heart failure, these drugs block neurohormonal changes. Acute coronary syndrome: A spectrum of problems ranging from ST-elevation MI to unstable angina that indicates the heart tissue is not receiving adequate supplies of oxygen. Acute heart
